Summary

The global Monoclonal Antibody Production Service market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Monoclonal antibody production service refers to a specialized laboratory service that involves the production of monoclonal antibodies using various techniques such as cell fusion, immunization, and screening. This service typically involves the preparation of immune cells, fusion of these cells with immortalized cell lines, and screening of antibody-secreting clones to identify monoclonal antibodies that bind specifically to a desired target antigen. The service involves a range of procedures including antibody purification, characterization, and optimization to ensure the production of high-quality antibodies with desired properties.
The industry trend for monoclonal antibody production service is towards increased demand in the pharmaceutical and biotechnology industries due to the growing need for advanced therapeutic and diagnostic tools. With the increasing use of monoclonal antibodies in oncology, autoimmune diseases, and other diseases, the need for reliable and efficient production services is increasing. Additionally, the trend towards more sustainable and environmentally friendly research and production methods is contributing to the growth of monoclonal antibody production services, as they reduce the use of harmful chemicals and minimize the environmental impact of antibody production. Furthermore, advancements in technology and bioinformatics are enabling more efficient and accurate production methods that are contributing to the increasing demand for monoclonal antibody production services.
The global Monoclonal Antibody Production Service market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
Bon Opus Biosciences
Biomatik
ProSci, Inc
Sino Biological
Thermo Fisher Scientific
RayBiotech
Cygnus Technologies
Sino Biological
BosterBio
Abeomics
Merck
Cayman Chemical
Hycult Biotech
GenScript
ProMab
R&D Systems
Rockland Immunochemicals
ProteoGenix
Evitria
ProteoGenix
Beijing Abace Biotechnology
Zoonbio Biotechnology
Beijing Biosynthesis Biotechnology
Cusabio
ChinaPeptides
Detaibio
Atagenix Laboratories
Segment by Type
Rabbit Monoclonal Antibodies
Mouse Monoclonal Antibodies
Human Monoclonal Antibodies
Others
Segment by Application
Biotechnology
Medical
University
Others
By Region
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Markets
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
(Additional regions can be customized based on client needs.)
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)
Chapter 2: Quantitative analysis of Monoclonal Antibody Production Service market size and growth potential at global, regional, and country levels
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities
Chapter 6: Regional revenue breakdown by company, type, application and customer
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Monoclonal Antibody Production Service value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Rabbit Monoclonal Antibodies
1.2.3 Mouse Monoclonal Antibodies
1.2.4 Human Monoclonal Antibodies
1.2.5 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Biotechnology
1.3.3 Medical
1.3.4 University
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Monoclonal Antibody Production Service Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Monoclonal Antibody Production Service Market Share by Revenue, by Region (2021-2026)
2.4 Global Monoclonal Antibody Production Service Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Monoclonal Antibody Production Service Market Size and Prospective (2021-2032)
2.5.2 Europe Monoclonal Antibody Production Service Market Size and Prospective (2021-2032)
2.5.3 Asia-Pacific Monoclonal Antibody Production Service Market Size and Prospective (2021-2032)
2.5.4 Latin America Monoclonal Antibody Production Service Market Size and Prospective (2021-2032)
2.5.5 Middle East & Africa Monoclonal Antibody Production Service Market Size and Prospective (2021-2032)
3 Breakdown Data by Type
3.1 Global Monoclonal Antibody Production Service Historical Market Size by Type (2021-2026)
3.2 Global Monoclonal Antibody Production Service Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Monoclonal Antibody Production Service
4 Breakdown Data by Application
4.1 Global Monoclonal Antibody Production Service Historical Market Size by Application (2021-2026)
4.2 Global Monoclonal Antibody Production Service Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in Monoclonal Antibody Production Service Applications
5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Monoclonal Antibody Production Service Players by Revenue (2021-2026)
5.1.2 Global Monoclonal Antibody Production Service Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Monoclonal Antibody Production Service Revenue
5.4 Global Monoclonal Antibody Production Service Market Concentration Analysis
5.4.1 Global Monoclonal Antibody Production Service Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Production Service Revenue in 2025
5.5 Global Key Players of Monoclonal Antibody Production Service Head Offices and Areas Served
5.6 Global Key Players of Monoclonal Antibody Production Service, Product and Application
5.7 Global Key Players of Monoclonal Antibody Production Service, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Monoclonal Antibody Production Service Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Monoclonal Antibody Production Service Market Size by Type (2021-2026)
6.1.2.2 North America Monoclonal Antibody Production Service Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America Monoclonal Antibody Production Service Market Size by Application (2021-2026)
6.1.3.2 North America Monoclonal Antibody Production Service Market Share by Application (2021-2026)
6.1.4 North America Monoclonal Antibody Production Service Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Monoclonal Antibody Production Service Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Monoclonal Antibody Production Service Market Size by Type (2021-2026)
6.2.2.2 Europe Monoclonal Antibody Production Service Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Monoclonal Antibody Production Service Market Size by Application (2021-2026)
6.2.3.2 Europe Monoclonal Antibody Production Service Market Share by Application (2021-2026)
6.2.4 Europe Monoclonal Antibody Production Service Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers
6.3.1 Asia-Pacific Monoclonal Antibody Production Service Revenue by Company (2021-2026)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Monoclonal Antibody Production Service Market Size by Type (2021-2026)
6.3.2.2 Asia-Pacific Monoclonal Antibody Production Service Market Share by Type (2021-2026)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific Monoclonal Antibody Production Service Market Size by Application (2021-2026)
6.3.3.2 Asia-Pacific Monoclonal Antibody Production Service Market Share by Application (2021-2026)
6.3.4 Asia-Pacific Monoclonal Antibody Production Service Major Customers
6.3.5 Asia-Pacific Market Trends and Opportunities
6.4 Latin America Market: Players, Segments, Downstream and Major Customers
6.4.1 Latin America Monoclonal Antibody Production Service Revenue by Company (2021-2026)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America Monoclonal Antibody Production Service Market Size by Type (2021-2026)
6.4.2.2 Latin America Monoclonal Antibody Production Service Market Share by Type (2021-2026)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America Monoclonal Antibody Production Service Market Size by Application (2021-2026)
6.4.3.2 Latin America Monoclonal Antibody Production Service Market Share by Application (2021-2026)
6.4.4 Latin America Monoclonal Antibody Production Service Major Customers
6.4.5 Latin America Market Trends and Opportunities
6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers
6.5.1 Middle East & Africa Monoclonal Antibody Production Service Revenue by Company (2021-2026)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa Monoclonal Antibody Production Service Market Size by Type (2021-2026)
6.5.2.2 Middle East & Africa Monoclonal Antibody Production Service Market Share by Type (2021-2026)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa Monoclonal Antibody Production Service Market Size by Application (2021-2026)
6.5.3.2 Middle East & Africa Monoclonal Antibody Production Service Market Share by Application (2021-2026)
6.5.4 Middle East & Africa Monoclonal Antibody Production Service Major Customers
6.5.5 Middle East & Africa Market Trends and Opportunities
7 Key Player Profiles
7.1 Bon Opus Biosciences
7.1.1 Bon Opus Biosciences Company Details
7.1.2 Bon Opus Biosciences Business Overview
7.1.3 Bon Opus Biosciences Monoclonal Antibody Production Service Introduction
7.1.4 Bon Opus Biosciences Revenue in Monoclonal Antibody Production Service Business (2021-2026)
7.1.5 Bon Opus Biosciences Recent Development
7.2 Biomatik
7.2.1 Biomatik Company Details
7.2.2 Biomatik Business Overview
7.2.3 Biomatik Monoclonal Antibody Production Service Introduction
7.2.4 Biomatik Revenue in Monoclonal Antibody Production Service Business (2021-2026)
7.2.5 Biomatik Recent Development
7.3 ProSci, Inc
7.3.1 ProSci, Inc Company Details
7.3.2 ProSci, Inc Business Overview
7.3.3 ProSci, Inc Monoclonal Antibody Production Service Introduction
7.3.4 ProSci, Inc Revenue in Monoclonal Antibody Production Service Business (2021-2026)
7.3.5 ProSci, Inc Recent Development
7.4 Sino Biological
7.4.1 Sino Biological Company Details
7.4.2 Sino Biological Business Overview
7.4.3 Sino Biological Monoclonal Antibody Production Service Introduction
7.4.4 Sino Biological Revenue in Monoclonal Antibody Production Service Business (2021-2026)
7.4.5 Sino Biological Recent Development
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Company Details
7.5.2 Thermo Fisher Scientific Business Overview
7.5.3 Thermo Fisher Scientific Monoclonal Antibody Production Service Introduction
7.5.4 Thermo Fisher Scientific Revenue in Monoclonal Antibody Production Service Business (2021-2026)
7.5.5 Thermo Fisher Scientific Recent Development
7.6 RayBiotech
7.6.1 RayBiotech Company Details
7.6.2 RayBiotech Business Overview
7.6.3 RayBiotech Monoclonal Antibody Production Service Introduction
7.6.4 RayBiotech Revenue in Monoclonal Antibody Production Service Business (2021-2026)
7.6.5 RayBiotech Recent Development
7.7 Cygnus Technologies
7.7.1 Cygnus Technologies Company Details
7.7.2 Cygnus Technologies Business Overview
7.7.3 Cygnus Technologies Monoclonal Antibody Production Service Introduction
7.7.4 Cygnus Technologies Revenue in Monoclonal Antibody Production Service Business (2021-2026)
7.7.5 Cygnus Technologies Recent Development
7.8 Sino Biological
7.8.1 Sino Biological Company Details
7.8.2 Sino Biological Business Overview
7.8.3 Sino Biological Monoclonal Antibody Production Service Introduction
7.8.4 Sino Biological Revenue in Monoclonal Antibody Production Service Business (2021-2026)
7.8.5 Sino Biological Recent Development
7.9 BosterBio
7.9.1 BosterBio Company Details
7.9.2 BosterBio Business Overview
7.9.3 BosterBio Monoclonal Antibody Production Service Introduction
7.9.4 BosterBio Revenue in Monoclonal Antibody Production Service Business (2021-2026)
7.9.5 BosterBio Recent Development
7.10 Abeomics
7.10.1 Abeomics Company Details
7.10.2 Abeomics Business Overview
7.10.3 Abeomics Monoclonal Antibody Production Service Introduction
7.10.4 Abeomics Revenue in Monoclonal Antibody Production Service Business (2021-2026)
7.10.5 Abeomics Recent Development
7.11 Merck
7.11.1 Merck Company Details
7.11.2 Merck Business Overview
7.11.3 Merck Monoclonal Antibody Production Service Introduction
7.11.4 Merck Revenue in Monoclonal Antibody Production Service Business (2021-2026)
7.11.5 Merck Recent Development
7.12 Cayman Chemical
7.12.1 Cayman Chemical Company Details
7.12.2 Cayman Chemical Business Overview
7.12.3 Cayman Chemical Monoclonal Antibody Production Service Introduction
7.12.4 Cayman Chemical Revenue in Monoclonal Antibody Production Service Business (2021-2026)
7.12.5 Cayman Chemical Recent Development
7.13 Hycult Biotech
7.13.1 Hycult Biotech Company Details
7.13.2 Hycult Biotech Business Overview
7.13.3 Hycult Biotech Monoclonal Antibody Production Service Introduction
7.13.4 Hycult Biotech Revenue in Monoclonal Antibody Production Service Business (2021-2026)
7.13.5 Hycult Biotech Recent Development
7.14 GenScript
7.14.1 GenScript Company Details
7.14.2 GenScript Business Overview
7.14.3 GenScript Monoclonal Antibody Production Service Introduction
7.14.4 GenScript Revenue in Monoclonal Antibody Production Service Business (2021-2026)
7.14.5 GenScript Recent Development
7.15 ProMab
7.15.1 ProMab Company Details
7.15.2 ProMab Business Overview
7.15.3 ProMab Monoclonal Antibody Production Service Introduction
7.15.4 ProMab Revenue in Monoclonal Antibody Production Service Business (2021-2026)
7.15.5 ProMab Recent Development
7.16 R&D Systems
7.16.1 R&D Systems Company Details
7.16.2 R&D Systems Business Overview
7.16.3 R&D Systems Monoclonal Antibody Production Service Introduction
7.16.4 R&D Systems Revenue in Monoclonal Antibody Production Service Business (2021-2026)
7.16.5 R&D Systems Recent Development
7.17 Rockland Immunochemicals
7.17.1 Rockland Immunochemicals Company Details
7.17.2 Rockland Immunochemicals Business Overview
7.17.3 Rockland Immunochemicals Monoclonal Antibody Production Service Introduction
7.17.4 Rockland Immunochemicals Revenue in Monoclonal Antibody Production Service Business (2021-2026)
7.17.5 Rockland Immunochemicals Recent Development
7.18 ProteoGenix
7.18.1 ProteoGenix Company Details
7.18.2 ProteoGenix Business Overview
7.18.3 ProteoGenix Monoclonal Antibody Production Service Introduction
7.18.4 ProteoGenix Revenue in Monoclonal Antibody Production Service Business (2021-2026)
7.18.5 ProteoGenix Recent Development
7.19 Evitria
7.19.1 Evitria Company Details
7.19.2 Evitria Business Overview
7.19.3 Evitria Monoclonal Antibody Production Service Introduction
7.19.4 Evitria Revenue in Monoclonal Antibody Production Service Business (2021-2026)
7.19.5 Evitria Recent Development
7.20 ProteoGenix
7.20.1 ProteoGenix Company Details
7.20.2 ProteoGenix Business Overview
7.20.3 ProteoGenix Monoclonal Antibody Production Service Introduction
7.20.4 ProteoGenix Revenue in Monoclonal Antibody Production Service Business (2021-2026)
7.20.5 ProteoGenix Recent Development
7.21 Beijing Abace Biotechnology
7.21.1 Beijing Abace Biotechnology Company Details
7.21.2 Beijing Abace Biotechnology Business Overview
7.21.3 Beijing Abace Biotechnology Monoclonal Antibody Production Service Introduction
7.21.4 Beijing Abace Biotechnology Revenue in Monoclonal Antibody Production Service Business (2021-2026)
7.21.5 Beijing Abace Biotechnology Recent Development
7.22 Zoonbio Biotechnology
7.22.1 Zoonbio Biotechnology Company Details
7.22.2 Zoonbio Biotechnology Business Overview
7.22.3 Zoonbio Biotechnology Monoclonal Antibody Production Service Introduction
7.22.4 Zoonbio Biotechnology Revenue in Monoclonal Antibody Production Service Business (2021-2026)
7.22.5 Zoonbio Biotechnology Recent Development
7.23 Beijing Biosynthesis Biotechnology
7.23.1 Beijing Biosynthesis Biotechnology Company Details
7.23.2 Beijing Biosynthesis Biotechnology Business Overview
7.23.3 Beijing Biosynthesis Biotechnology Monoclonal Antibody Production Service Introduction
7.23.4 Beijing Biosynthesis Biotechnology Revenue in Monoclonal Antibody Production Service Business (2021-2026)
7.23.5 Beijing Biosynthesis Biotechnology Recent Development
7.24 Cusabio
7.24.1 Cusabio Company Details
7.24.2 Cusabio Business Overview
7.24.3 Cusabio Monoclonal Antibody Production Service Introduction
7.24.4 Cusabio Revenue in Monoclonal Antibody Production Service Business (2021-2026)
7.24.5 Cusabio Recent Development
7.25 ChinaPeptides
7.25.1 ChinaPeptides Company Details
7.25.2 ChinaPeptides Business Overview
7.25.3 ChinaPeptides Monoclonal Antibody Production Service Introduction
7.25.4 ChinaPeptides Revenue in Monoclonal Antibody Production Service Business (2021-2026)
7.25.5 ChinaPeptides Recent Development
7.26 Detaibio
7.26.1 Detaibio Company Details
7.26.2 Detaibio Business Overview
7.26.3 Detaibio Monoclonal Antibody Production Service Introduction
7.26.4 Detaibio Revenue in Monoclonal Antibody Production Service Business (2021-2026)
7.26.5 Detaibio Recent Development
7.27 Atagenix Laboratories
7.27.1 Atagenix Laboratories Company Details
7.27.2 Atagenix Laboratories Business Overview
7.27.3 Atagenix Laboratories Monoclonal Antibody Production Service Introduction
7.27.4 Atagenix Laboratories Revenue in Monoclonal Antibody Production Service Business (2021-2026)
7.27.5 Atagenix Laboratories Recent Development
8 Monoclonal Antibody Production Service Market Dynamics
8.1 Monoclonal Antibody Production Service Industry Trends
8.2 Monoclonal Antibody Production Service Market Drivers
8.3 Monoclonal Antibody Production Service Market Challenges
8.4 Monoclonal Antibody Production Service Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Monoclonal Antibody Production Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global Monoclonal Antibody Production Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market Monoclonal Antibody Production Service Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global Monoclonal Antibody Production Service Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global Monoclonal Antibody Production Service Revenue Share by Region (2021-2026)
Table 6. Global Monoclonal Antibody Production Service Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global Monoclonal Antibody Production Service Revenue Share Forecast by Region (2027-2032)
Table 8. Global Monoclonal Antibody Production Service Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global Monoclonal Antibody Production Service Market Share by Revenue, by Type (2021-2026)
Table 10. Global Monoclonal Antibody Production Service Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global Monoclonal Antibody Production Service Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global Monoclonal Antibody Production Service Market Size by Application (2021-2026) & (US$ Million)
Table 14. Global Monoclonal Antibody Production Service Market Share by Revenue, by Application (2021-2026)
Table 15. Global Monoclonal Antibody Production Service Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 16. Global Monoclonal Antibody Production Service Market Share by Revenue, by Application (2027-2032)
Table 17. New Sources of Growth in Monoclonal Antibody Production Service Applications
Table 18. Global Monoclonal Antibody Production Service Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global Monoclonal Antibody Production Service Market Share by Players (2021-2026)
Table 20. Global Top Monoclonal Antibody Production Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Production Service as of 2025)
Table 21. Ranking of Global Top Monoclonal Antibody Production Service Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Monoclonal Antibody Production Service Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of Monoclonal Antibody Production Service, Headquarters and Area Served
Table 24. Global Key Players of Monoclonal Antibody Production Service, Product and Application
Table 25. Global Key Players of Monoclonal Antibody Production Service, Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Monoclonal Antibody Production Service Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America Monoclonal Antibody Production Service Market Share by Revenue, by Company (2021-2026)
Table 29. North America Monoclonal Antibody Production Service Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America Monoclonal Antibody Production Service Market Size by Application (2021-2026) & (US$ Million)
Table 31. Europe Monoclonal Antibody Production Service Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe Monoclonal Antibody Production Service Market Share by Revenue, by Company (2021-2026)
Table 33. Europe Monoclonal Antibody Production Service Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe Monoclonal Antibody Production Service Market Size by Application (2021-2026) & (US$ Million)
Table 35. Asia-Pacific Monoclonal Antibody Production Service Revenue by Company (2021-2026) & (US$ Million)
Table 36. Asia-Pacific Monoclonal Antibody Production Service Market Share by Revenue, by Company (2021-2026)
Table 37. Asia-Pacific Monoclonal Antibody Production Service Market Size by Type (2021-2026) & (US$ Million)
Table 38. Asia-Pacific Monoclonal Antibody Production Service Market Size by Application (2021-2026) & (US$ Million)
Table 39. Latin America Monoclonal Antibody Production Service Revenue by Company (2021-2026) & (US$ Million)
Table 40. Latin America Monoclonal Antibody Production Service Market Share by Revenue, by Company (2021-2026)
Table 41. Latin America Monoclonal Antibody Production Service Market Size by Type (2021-2026) & (US$ Million)
Table 42. Latin America Monoclonal Antibody Production Service Market Size by Application (2021-2026) & (US$ Million)
Table 43. Middle East & Africa Monoclonal Antibody Production Service Revenue by Company (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Monoclonal Antibody Production Service Market Share by Revenue, by Company (2021-2026)
Table 45. Middle East & Africa Monoclonal Antibody Production Service Market Size by Type (2021-2026) & (US$ Million)
Table 46. Middle East & Africa Monoclonal Antibody Production Service Market Size by Application (2021-2026) & (US$ Million)
Table 47. Bon Opus Biosciences Company Details
Table 48. Bon Opus Biosciences Business Overview
Table 49. Bon Opus Biosciences Monoclonal Antibody Production Service Product
Table 50. Bon Opus Biosciences Revenue in Monoclonal Antibody Production Service Business (2021-2026) & (US$ Million)
Table 51. Bon Opus Biosciences Recent Development
Table 52. Biomatik Company Details
Table 53. Biomatik Business Overview
Table 54. Biomatik Monoclonal Antibody Production Service Product
Table 55. Biomatik Revenue in Monoclonal Antibody Production Service Business (2021-2026) & (US$ Million)
Table 56. Biomatik Recent Development
Table 57. ProSci, Inc Company Details
Table 58. ProSci, Inc Business Overview
Table 59. ProSci, Inc Monoclonal Antibody Production Service Product
Table 60. ProSci, Inc Revenue in Monoclonal Antibody Production Service Business (2021-2026) & (US$ Million)
Table 61. ProSci, Inc Recent Development
Table 62. Sino Biological Company Details
Table 63. Sino Biological Business Overview
Table 64. Sino Biological Monoclonal Antibody Production Service Product
Table 65. Sino Biological Revenue in Monoclonal Antibody Production Service Business (2021-2026) & (US$ Million)
Table 66. Sino Biological Recent Development
Table 67. Thermo Fisher Scientific Company Details
Table 68. Thermo Fisher Scientific Business Overview
Table 69. Thermo Fisher Scientific Monoclonal Antibody Production Service Product
Table 70. Thermo Fisher Scientific Revenue in Monoclonal Antibody Production Service Business (2021-2026) & (US$ Million)
Table 71. Thermo Fisher Scientific Recent Development
Table 72. RayBiotech Company Details
Table 73. RayBiotech Business Overview
Table 74. RayBiotech Monoclonal Antibody Production Service Product
Table 75. RayBiotech Revenue in Monoclonal Antibody Production Service Business (2021-2026) & (US$ Million)
Table 76. RayBiotech Recent Development
Table 77. Cygnus Technologies Company Details
Table 78. Cygnus Technologies Business Overview
Table 79. Cygnus Technologies Monoclonal Antibody Production Service Product
Table 80. Cygnus Technologies Revenue in Monoclonal Antibody Production Service Business (2021-2026) & (US$ Million)
Table 81. Cygnus Technologies Recent Development
Table 82. Sino Biological Company Details
Table 83. Sino Biological Business Overview
Table 84. Sino Biological Monoclonal Antibody Production Service Product
Table 85. Sino Biological Revenue in Monoclonal Antibody Production Service Business (2021-2026) & (US$ Million)
Table 86. Sino Biological Recent Development
Table 87. BosterBio Company Details
Table 88. BosterBio Business Overview
Table 89. BosterBio Monoclonal Antibody Production Service Product
Table 90. BosterBio Revenue in Monoclonal Antibody Production Service Business (2021-2026) & (US$ Million)
Table 91. BosterBio Recent Development
Table 92. Abeomics Company Details
Table 93. Abeomics Business Overview
Table 94. Abeomics Monoclonal Antibody Production Service Product
Table 95. Abeomics Revenue in Monoclonal Antibody Production Service Business (2021-2026) & (US$ Million)
Table 96. Abeomics Recent Development
Table 97. Merck Company Details
Table 98. Merck Business Overview
Table 99. Merck Monoclonal Antibody Production Service Product
Table 100. Merck Revenue in Monoclonal Antibody Production Service Business (2021-2026) & (US$ Million)
Table 101. Merck Recent Development
Table 102. Cayman Chemical Company Details
Table 103. Cayman Chemical Business Overview
Table 104. Cayman Chemical Monoclonal Antibody Production Service Product
Table 105. Cayman Chemical Revenue in Monoclonal Antibody Production Service Business (2021-2026) & (US$ Million)
Table 106. Cayman Chemical Recent Development
Table 107. Hycult Biotech Company Details
Table 108. Hycult Biotech Business Overview
Table 109. Hycult Biotech Monoclonal Antibody Production Service Product
Table 110. Hycult Biotech Revenue in Monoclonal Antibody Production Service Business (2021-2026) & (US$ Million)
Table 111. Hycult Biotech Recent Development
Table 112. GenScript Company Details
Table 113. GenScript Business Overview
Table 114. GenScript Monoclonal Antibody Production Service Product
Table 115. GenScript Revenue in Monoclonal Antibody Production Service Business (2021-2026) & (US$ Million)
Table 116. GenScript Recent Development
Table 117. ProMab Company Details
Table 118. ProMab Business Overview
Table 119. ProMab Monoclonal Antibody Production Service Product
Table 120. ProMab Revenue in Monoclonal Antibody Production Service Business (2021-2026) & (US$ Million)
Table 121. ProMab Recent Development
Table 122. R&D Systems Company Details
Table 123. R&D Systems Business Overview
Table 124. R&D Systems Monoclonal Antibody Production Service Product
Table 125. R&D Systems Revenue in Monoclonal Antibody Production Service Business (2021-2026) & (US$ Million)
Table 126. R&D Systems Recent Development
Table 127. Rockland Immunochemicals Company Details
Table 128. Rockland Immunochemicals Business Overview
Table 129. Rockland Immunochemicals Monoclonal Antibody Production Service Product
Table 130. Rockland Immunochemicals Revenue in Monoclonal Antibody Production Service Business (2021-2026) & (US$ Million)
Table 131. Rockland Immunochemicals Recent Development
Table 132. ProteoGenix Company Details
Table 133. ProteoGenix Business Overview
Table 134. ProteoGenix Monoclonal Antibody Production Service Product
Table 135. ProteoGenix Revenue in Monoclonal Antibody Production Service Business (2021-2026) & (US$ Million)
Table 136. ProteoGenix Recent Development
Table 137. Evitria Company Details
Table 138. Evitria Business Overview
Table 139. Evitria Monoclonal Antibody Production Service Product
Table 140. Evitria Revenue in Monoclonal Antibody Production Service Business (2021-2026) & (US$ Million)
Table 141. Evitria Recent Development
Table 142. ProteoGenix Company Details
Table 143. ProteoGenix Business Overview
Table 144. ProteoGenix Monoclonal Antibody Production Service Product
Table 145. ProteoGenix Revenue in Monoclonal Antibody Production Service Business (2021-2026) & (US$ Million)
Table 146. ProteoGenix Recent Development
Table 147. Beijing Abace Biotechnology Company Details
Table 148. Beijing Abace Biotechnology Business Overview
Table 149. Beijing Abace Biotechnology Monoclonal Antibody Production Service Product
Table 150. Beijing Abace Biotechnology Revenue in Monoclonal Antibody Production Service Business (2021-2026) & (US$ Million)
Table 151. Beijing Abace Biotechnology Recent Development
Table 152. Zoonbio Biotechnology Company Details
Table 153. Zoonbio Biotechnology Business Overview
Table 154. Zoonbio Biotechnology Monoclonal Antibody Production Service Product
Table 155. Zoonbio Biotechnology Revenue in Monoclonal Antibody Production Service Business (2021-2026) & (US$ Million)
Table 156. Zoonbio Biotechnology Recent Development
Table 157. Beijing Biosynthesis Biotechnology Company Details
Table 158. Beijing Biosynthesis Biotechnology Business Overview
Table 159. Beijing Biosynthesis Biotechnology Monoclonal Antibody Production Service Product
Table 160. Beijing Biosynthesis Biotechnology Revenue in Monoclonal Antibody Production Service Business (2021-2026) & (US$ Million)
Table 161. Beijing Biosynthesis Biotechnology Recent Development
Table 162. Cusabio Company Details
Table 163. Cusabio Business Overview
Table 164. Cusabio Monoclonal Antibody Production Service Product
Table 165. Cusabio Revenue in Monoclonal Antibody Production Service Business (2021-2026) & (US$ Million)
Table 166. Cusabio Recent Development
Table 167. ChinaPeptides Company Details
Table 168. ChinaPeptides Business Overview
Table 169. ChinaPeptides Monoclonal Antibody Production Service Product
Table 170. ChinaPeptides Revenue in Monoclonal Antibody Production Service Business (2021-2026) & (US$ Million)
Table 171. ChinaPeptides Recent Development
Table 172. Detaibio Company Details
Table 173. Detaibio Business Overview
Table 174. Detaibio Monoclonal Antibody Production Service Product
Table 175. Detaibio Revenue in Monoclonal Antibody Production Service Business (2021-2026) & (US$ Million)
Table 176. Detaibio Recent Development
Table 177. Atagenix Laboratories Company Details
Table 178. Atagenix Laboratories Business Overview
Table 179. Atagenix Laboratories Monoclonal Antibody Production Service Product
Table 180. Atagenix Laboratories Revenue in Monoclonal Antibody Production Service Business (2021-2026) & (US$ Million)
Table 181. Atagenix Laboratories Recent Development
Table 182. Monoclonal Antibody Production Service Market Trends
Table 183. Monoclonal Antibody Production Service Market Drivers
Table 184. Monoclonal Antibody Production Service Market Challenges
Table 185. Monoclonal Antibody Production Service Market Restraints
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources


List of Figures
Figure 1. Monoclonal Antibody Production Service Product Picture
Figure 2. Global Monoclonal Antibody Production Service Market Share by Type: 2025 vs 2032
Figure 3. Rabbit Monoclonal Antibodies Features
Figure 4. Mouse Monoclonal Antibodies Features
Figure 5. Human Monoclonal Antibodies Features
Figure 6. Others Features
Figure 7. Global Monoclonal Antibody Production Service Market Share by Application: 2025 vs 2032
Figure 8. Biotechnology
Figure 9. Medical
Figure 10. University
Figure 11. Others
Figure 12. Monoclonal Antibody Production Service Report Years Considered
Figure 13. Global Monoclonal Antibody Production Service Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 14. Global Monoclonal Antibody Production Service Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Monoclonal Antibody Production Service Market Share by Revenue, by Region: 2021 vs 2025
Figure 16. North America Monoclonal Antibody Production Service Revenue (US$ Million) Growth Rate (2021-2032)
Figure 17. Europe Monoclonal Antibody Production Service Revenue (US$ Million) Growth Rate (2021-2032)
Figure 18. Asia-Pacific Monoclonal Antibody Production Service Revenue (US$ Million) Growth Rate (2021-2032)
Figure 19. Latin America Monoclonal Antibody Production Service Revenue (US$ Million) Growth Rate (2021-2032)
Figure 20. Middle East & Africa Monoclonal Antibody Production Service Revenue (US$ Million) Growth Rate (2021-2032)
Figure 21. Global Monoclonal Antibody Production Service Market Share by Players in 2025
Figure 22. Global Top Monoclonal Antibody Production Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Production Service as of 2025)
Figure 23. The Top 10 and 5 Players Market Share by Monoclonal Antibody Production Service Revenue in 2025
Figure 24. North America Monoclonal Antibody Production Service Market Share by Type (2021-2026)
Figure 25. North America Monoclonal Antibody Production Service Market Share by Application (2021-2026)
Figure 26. Europe Monoclonal Antibody Production Service Market Share by Type (2021-2026)
Figure 27. Europe Monoclonal Antibody Production Service Market Share by Application (2021-2026)
Figure 28. Asia-Pacific Monoclonal Antibody Production Service Market Share by Type (2021-2026)
Figure 29. Asia-Pacific Monoclonal Antibody Production Service Market Share by Application (2021-2026)
Figure 30. Latin America Monoclonal Antibody Production Service Market Share by Type (2021-2026)
Figure 31. Latin America Monoclonal Antibody Production Service Market Share by Application (2021-2026)
Figure 32. Middle East & Africa Monoclonal Antibody Production Service Market Share by Type (2021-2026)
Figure 33. Middle East & Africa Monoclonal Antibody Production Service Market Share by Application (2021-2026)
Figure 34. Bon Opus Biosciences Revenue Growth Rate in Monoclonal Antibody Production Service Business (2021-2026)
Figure 35. Biomatik Revenue Growth Rate in Monoclonal Antibody Production Service Business (2021-2026)
Figure 36. ProSci, Inc Revenue Growth Rate in Monoclonal Antibody Production Service Business (2021-2026)
Figure 37. Sino Biological Revenue Growth Rate in Monoclonal Antibody Production Service Business (2021-2026)
Figure 38. Thermo Fisher Scientific Revenue Growth Rate in Monoclonal Antibody Production Service Business (2021-2026)
Figure 39. RayBiotech Revenue Growth Rate in Monoclonal Antibody Production Service Business (2021-2026)
Figure 40. Cygnus Technologies Revenue Growth Rate in Monoclonal Antibody Production Service Business (2021-2026)
Figure 41. Sino Biological Revenue Growth Rate in Monoclonal Antibody Production Service Business (2021-2026)
Figure 42. BosterBio Revenue Growth Rate in Monoclonal Antibody Production Service Business (2021-2026)
Figure 43. Abeomics Revenue Growth Rate in Monoclonal Antibody Production Service Business (2021-2026)
Figure 44. Merck Revenue Growth Rate in Monoclonal Antibody Production Service Business (2021-2026)
Figure 45. Cayman Chemical Revenue Growth Rate in Monoclonal Antibody Production Service Business (2021-2026)
Figure 46. Hycult Biotech Revenue Growth Rate in Monoclonal Antibody Production Service Business (2021-2026)
Figure 47. GenScript Revenue Growth Rate in Monoclonal Antibody Production Service Business (2021-2026)
Figure 48. ProMab Revenue Growth Rate in Monoclonal Antibody Production Service Business (2021-2026)
Figure 49. R&D Systems Revenue Growth Rate in Monoclonal Antibody Production Service Business (2021-2026)
Figure 50. Rockland Immunochemicals Revenue Growth Rate in Monoclonal Antibody Production Service Business (2021-2026)
Figure 51. ProteoGenix Revenue Growth Rate in Monoclonal Antibody Production Service Business (2021-2026)
Figure 52. Evitria Revenue Growth Rate in Monoclonal Antibody Production Service Business (2021-2026)
Figure 53. ProteoGenix Revenue Growth Rate in Monoclonal Antibody Production Service Business (2021-2026)
Figure 54. Beijing Abace Biotechnology Revenue Growth Rate in Monoclonal Antibody Production Service Business (2021-2026)
Figure 55. Zoonbio Biotechnology Revenue Growth Rate in Monoclonal Antibody Production Service Business (2021-2026)
Figure 56. Beijing Biosynthesis Biotechnology Revenue Growth Rate in Monoclonal Antibody Production Service Business (2021-2026)
Figure 57. Cusabio Revenue Growth Rate in Monoclonal Antibody Production Service Business (2021-2026)
Figure 58. ChinaPeptides Revenue Growth Rate in Monoclonal Antibody Production Service Business (2021-2026)
Figure 59. Detaibio Revenue Growth Rate in Monoclonal Antibody Production Service Business (2021-2026)
Figure 60. Atagenix Laboratories Revenue Growth Rate in Monoclonal Antibody Production Service Business (2021-2026)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed